Feedback / Questions
ANK-101 - Ankyra Therap
https://www.businesswire.com/news/home/20231014584851/en/Ankyra-Therapeutics-Presents-Preliminary-Phase-1-Canine-Clinical-Data-Evaluating-cANK-101-to-Treat-Advanced-Malignant-Melanoma-in-Dogs
Oct 14, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next